AnilKSoodMD

PubMed

• Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy.
  Sara Corvigno, Yuan Liu, Emine Bayraktar, Elaine Stur, Nazende Nur Bayram, Adrian Lankenau Ahumada, Supriya Nagaraju, Cristian Rodriguez-Aguayo, Hu Chen, Thanh Chung V...> ;NPJ Precision Oncology. 2024 Apr 6
• Angiogenesis-Enabled Human Ovarian Tumor Microenvironment-Chip Evaluates Pathophysiology of Platelets in Microcirculation.
  Lopamudra D Ghosh, Tanmay Mathur, James J Tronolone, Ashley Chuong, Kelly Rangel, Sara Corvigno, Abhishek Jain, Anil K Sood> ;Advanced Healthcare Materials. 2024 Mar 30
• Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
  Anne Knisely, Emily Hinchcliff, Bryan Fellman, Ann Mosley, Kathryn Lito, Sara Hull, Shannon N Westin, Anil K Sood, Kathleen M Schmeler, Jolyn S Taylor, Steven Y Huang,...> ;Med. 2024 Apr 12
• Rural-urban disparities in psychosocial functioning in epithelial ovarian cancer patients.
  Telles, R., Zimmerman, M., Slavich, G., Ramirez, E., Zia, S., Cole, S., Lutgendorf, S., Thaker, P., Goodheart, M., Sood, A.> ;Gynecologic Oncology. 2024 Feb 2
• EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
  Joseph, R., Dasari, S., Umamaheswaran, S., Mangala, L., Bayraktar, E., Rodriguez-Aguayo, C., Wu, Y., Nguyen, N., Powell, R., Sobieski, M., Liu, Y., Kim, M., Corvigno, ...> ;International Journal of Molecular Sciences. 2024 Jan 20
• Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
  Legarreta, A., Fellman, B., Foster, K., Vuttaradhi, V., Brodsky, A., Hillman, R., How, J., Handley, K., Glassman, D., Lawson, B., Westin, S., Ramondetta, L., Gershenso...> ;American Journal of Obstetrics and Gynecology. 2024 Jan 6
• Editorial: Platelets in tumor biology: from molecular mechanisms to clinical applications.
  Aris, M., Zaslavsky, A., Sood, A.> ;Frontiers in Cell and Developmental Biology. 2024 Jan 1
• PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
  Li, Y., Dobrolecki, L., Sallas, C., Zhang, X., Kerr, T., Bisht, D., Wang, Y., Awasthi, S., Kaundal, B., Wu, S., Peng, W., Mendillo, M., Lu, Y., Jeter, C., Peng, G., Li...> ;Cell Reports. Medicine. 2023 Dec 19
• 1 citations
  The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients.
  Lutgendorf, S., Telles, R., Whitney, B., Slavich, G., Penedo, F., Noble, A., Cole, S., Corn, B., Thaker, P., Goodheart, M., Sood, A.> ;Brain, Behavior, and Immunity. 2024 Feb 1
• Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
  Emily M Hinchcliff, Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel, Cai Xu, Shannon N Westin, Anil K Sood, Pamela T Soliman, Aaron Shafer, Nicole D Fle...> ;Cancer. 2024 Apr 1
• In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.
  Sara Corvigno, Sunil Badal, Meredith L Spradlin, Michael Keating, Igor Pereira, Elaine Stur, Emine Bayraktar, Katherine I Foster, Nicholas W Bateman, Waleed Barakat, K...> ;NPJ Precision Oncology. 2023 Nov 3
• Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins.
  Daniel J McGrail, Yang Li, Roger S Smith, Bin Feng, Hui Dai, Limei Hu, Briana Dennehey, Sharad Awasthi, Marc L Mendillo, Anil K Sood, Gordon B Mills, Shiaw-Yih Lin, S ...> ;Cell Reports. Medicine. 2023 Nov 21
• 1 citations
  Low-grade serous ovarian cancer: expert consensus report on the state of the science.
  Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, Susana Banerjee, Jubilee Brown, Mark S Carey, Herman Chui, Robert L Coleman, Amanda N Fader, Stephanie Gaillard, C...> ;International Journal of Gynecological Cancer. 2023 Sep 4
• 1 citations
  Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic.
  Rachel Telles, Sharaf Zia, Breanna B Greteman, Premal H Thaker, Frank Penedo, Mary E Charlton, Michael J Goodheart, Jessica S Armer, Alyssa Noble, Anil K Sood, Susan K...> ;Journal of Psychosocial Oncology. 2023 Aug 17
• 6 citations
  Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer.
  Xudong Zhang, Jun Yao, Xiaoran Li, Na Niu, Yan Liu, Richard A Hajek, Guang Peng, Shannon Westin, Anil K Sood, Jinsong Liu> ;Science Advances. 2023 Jul 21
• A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
  Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah, Anil K Sood, Jordi Rodon, Daniel D Karp, George Blumenschein, Scott Kopetz, Shu...> ;The Oncologist. 2023 Dec 11
• 1 citations
  Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.
  Koji Matsuo, Shinya Matsuzaki, Michihide Maeda, Alesandra R Rau, Kosuke Yoshihara, Ryo Tamura, Muneaki Shimada, Hiroko Machida, Mikio Mikami, Maximilian Klar, Lynda D ...> ;JAMA Network Open. 2023 Jun 1
• 8 citations
  Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
  Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina ...> ;Nature Communications. 2023 Apr 26
• 2 citations
  Enhancing oral delivery of plant-derived vesicles for colitis.
  Yuan Liu, Adrian Lankenau Ahumada, Emine Bayraktar, Paul Schwartz, Mamur Chowdhury, Sixiang Shi, Manu M Sebastian, Htet Khant, Natalia de Val, Nazende Nur Bayram, Guod...> ;Journal of Controlled Release. 2023 May 1
• 1 citations
  Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.
  Katherine I Foster, Katelyn F Handley, Deanna Glassman, Travis T Sims, Sanaz Javadi, Sarah M Palmquist, Mohammed M Saleh, Bryan M Fellman, Nicole D Fleming, Priya R Bh...> ;International Journal of Gynecological Cancer. 2023 Jun 5
• 1 citations
  Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
  Katherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, Katelyn F Handley, Deanna Glassman, Jeffrey A How, Barrett C Lawson, Shannon N Westin, Lois M Ramondetta, M...> ;American Journal of Obstetrics and Gynecology. 2023 Jun 1
• 1 citations
  Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer.
  Deanna Glassman, Mark S Kim, Meredith Spradlin, Sunil Badal, Mana Taki, Pratip Bhattacharya, Prasanta Dutta, Charles V Kingsley, Katherine I Foster, Olamide Animasahun...> ;Iscience. 2023 Feb 17
• 4 citations
  Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
  Santosh K Dasari, Robiya Joseph, Sujanitha Umamaheswaran, Lingegowda S Mangala, Emine Bayraktar, Cristian Rodriguez-Aguayo, Yutuan Wu, Nghi Nguyen, Reid T Powell, Mary...> ;International Journal of Molecular Sciences. 2023 Feb 15
• 2 citations
  SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
  Xudong Zhang, Jun Yao, Na Niu, Xiaoran Li, Yan Liu, Lei Huo, Elizabeth D Euscher, Huamin Wang, Diana Bell, Anil K Sood, Guoliang Wang, Barrett C Lawson, Preetha Ramali...> ;Modern Pathology. 2023 Feb 1
• 12 citations
  Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells.
  Xiaoran Li, Yanping Zhong, Xudong Zhang, Anil K Sood, Jinsong Liu> ;Oncogene. 2023 Feb 1
• Join now to see all

Journal Articles

• Minimally Invasive Surgery and Risk of Capsule Rupture for Women with Early-Stage Ovarian Cancer  
  Koji Matsuo, Lynda D Roman, Anil K Sood, JAMA Oncology
• Minimally Invasive Surgery and Risk of Capsule Rupture for Women with Early-Stage Ovarian Cancer  
  Lynda D Roman, Anil K Sood, JAMA Oncology
• EGFL6 Promotes Breast Cancer by Simultaneously Enhancing Cancer Cell Metastasis and Stimulating Tumor Angiogenesis  
  Xuejun Fan, Anil K Sood, Nature
• CD44-Targeted PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer  
  Anil Sood, MD, Clinical Cancer Research
• FABP4 as a Key Determinant of Metastatic Potential of Ovarian Cancer  
  Jinsong Liu, Anil K Sood, Nature
• Paclitaxel Sensitivity of Ovarian Cancer Can Be Enhanced by Knocking down Pairs of Kinases That Regulate MAP4 Phosphorylation and Microtubule Stability  
  Robert C Bast, Anil K Sood, Clinical Cancer Research
• Life Stress as a Risk Factor for Sustained Anxiety and Cortisol Dysregulation During the First Year of Survivorship in Ovarian Cancer  
  Anil K Sood, Premal H Thaker, Laila Dahmoush, Cancer
• A-to-I miR-378a-3p Editing Can Prevent Melanoma Progression via Regulation of PARVA Expression  
  Anil Sood, MD, Nature
• Stress Hormones Promote EGFR Inhibitor Resistance in NSCLC: Implications for Combinations with Β-blockers  
  Hai Tran, Anil K Sood, John V Heymach, Roy Herbst, Lecia V Sequist, Edward S Kim, Science Magazine
• Join now to see all